Epidemiology of the β-lactamase resistome among Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in the Chicago region

Similar documents
Determining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing

Carbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools.

10/4/16. mcr-1. Emerging Resistance Updates. Objectives. National Center for Emerging and Zoonotic Infectious Diseases. Alex Kallen, MD, MPH, FACP

Update on CLSI and EUCAST

β-lactamase inhibitors

β- Lactamase Gene carrying Klebsiella pneumoniae and its Clinical Implication

Public Health Surveillance for Multi Drug Resistant Organisms in Orange County

The Public Health Benefit of CRE Colonization Testing

Enterobacteriaceae with acquired carbapenemases, 2016

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); July 2014.

ALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella

ST11 KPC-2 Klebsiella pneumoniae detected in Taiwan

Under the radar. Two prolonged outbreaks of carbapenemase-producing Enterobacteriaceae (CPE) at a tertiary hospital in Canberra, Australia

Genetic Analysis of Organisms Isolated From the ICU

Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria from ICU Patients with Pneumonia

Received 31 January 2011/Returned for modification 2 March 2011/Accepted 15 March 2011

Regional Emergence of VIM producing carbapenem resistant Pseudomonas aeruginosa (VIM CRPA)

Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test

Carbapenems and Enterobacteriaceae

Carbapenemases in Enterobacteriaceae: Prof P. Nordmann Bicêtre hospital, South-Paris Med School

Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae in Taiwan

Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011

The role of an AMR reference laboratory

Discussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category

Overcoming the PosESBLities of Enterobacteriaceae Resistance

PROFESSOR PETER M. HAWKEY

Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory

Results and experience of BARN ESBL project. Marina Ivanova and project team Tallinn

AAC Accepts, published online ahead of print on 13 October 2008 Antimicrob. Agents Chemother. doi: /aac

jmb Research Article Review Semi Kim 1, Ji Youn Sung 2, Hye Hyun Cho 3, Kye Chul Kwon 1, and Sun Hoe Koo 1 *

#Corresponding author: Pathology Department, Singapore General Hospital, 20 College. Road, Academia, Level 7, Diagnostics Tower, , Singapore

Epidemiology of ESBL in hospitals and in the community

Global Epidemiology of Carbapenem- Resistant Enterobacteriaceae (CRE)

Academic Perspective in. David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic resistance PHE

Emergence of non-kpc carbapenemases: NDM and more

Impact of Extended Spectrum Beta-Lactamase Producing Klebsiella pneumoniae Infections in Severely Burned Patients

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae

Enterobacteriaceae with acquired carbapenemases, 2015

Recommendations for the Management of Carbapenem- Resistant Enterobacteriaceae (CRE) in Acute and Long-term Acute Care Hospitals

Disclosure. Objectives. Evolution of β Lactamases. Extended Spectrum β Lactamases: The New Normal. Prevalence of ESBL Mystic Program

Lane CR, Kwong JC, Romanes F, Easton M, Cronin K, Waters MJ, Stevens K, Schultz MB, Sherry NL, Tai A, Ballard SA, Seemann T, Stinear T & Howden BP

Educational Workshops 2016

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

ORIGINAL ARTICLE. Julie Creighton and Clare Tibbs. Canterbury Health Laboratories, Christchurch

Validating a selection method for. H. Hasman, Y. Agersø, C. Svendsen, H. Nielsen, N.S. Jensen, B. Guerra, Aarestrup, FM

Phenotypic detection of ESBLs and carbapenemases

A new diagnostic microarray (Check-KPC ESBL) for detection and. identification of extended-spectrum beta-lactamases in highly resistant

Investigation of a Giardia Cluster Associated with a Private Club, Cook County, 2011

Guidelines. 14 Nov Marc Bonten

Navigating Through Current and Emerging Issues in Outbreaks

Detecting carbapenemases in Enterobacteriaceae

Toolkit for the Management of Carbapenemase Producing Organisms (CPO)

Carbapenem-resistant Enterobacteriaceae (CRE): Coming to a hospital near you?

Detection of NDM-1-producing Klebsiella pneumoniae in Kenya

New Mechanisms of Antimicrobial Resistance and Methods for Carbapenemase Detection

Rapid identification of emerging resistance in Gram negatives. Prof. Patrice Nordmann

Clinical Management of Infections Caused by Enterobacteriaceae that Express Extended- Spectrum β-lactamase and AmpC Enzymes

Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong. Title. Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH

Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study

Enterobacteriaceae in Bamako, Mali. Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, CHU Reims, UFR Médecine

Revised AAC Version 2» New-Data Letter to the Editor ACCEPTED. Plasmid-Mediated Carbapenem-Hydrolyzing β-lactamase KPC-2 in

Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by MALDI- TOF mass spectrometry

Carbapenemase-producing Enterobacteriaceae

ESBL s. BL s, ESBL s,

Emerging Infections, Outbreaks, and Steps of an Outbreak Investigation Across the Healthcare Continuum

Screening and detection of carbapenemases

JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p Vol. 36, No. 9. Copyright 1998, American Society for Microbiology. All Rights Reserved.

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator

Burns outbreaks - the UHB experience

MALDI-TOF MS: a new tool to rapidly assess antibiotic susceptibility

Abstract. Introduction. Editor: R. Canton

ORIGINAL INVESTIGATION. Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City

Burns outbreaks - the UHB experience

Extended-Spectrum -Lactamases: a Clinical Update

LABORATORY TRENDS. International Accreditation BC PUBLIC HEALTH MICROBIOLOGY & REFERENCE LABORATORY. Vancouver, BC. March 15, 2013.

Molecular β-lactamase characterization of aerobic Gram-negative pathogens recovered from patients

Abstract. a Jann-Tay Wang 1, Un-In Wu 2, Tsai-Ling Yang Lauderdale 3, Mei-Chen Chen 3, Shu-Ying Li 4, Le-Yin Hsu 5, Shan-Chwen Chang 1,6 *

MHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions

Detecting CRE. what does one need to do?

Infection Control Strategies to Avoid Carbapenam Resistance in Hospitals. Victor Lim International Medical University Malaysia

In Vitro Activity of Ceftazidime-Avibactam Against Isolates. in a Phase 3 Open-label Clinical Trial for Complicated

HOSPITAL EPIDEMOLOGY AND INFECTION CONTROL: STANDARD AND TRANSMISSION-BASED ISOLATION

KPC around the world Maria Virginia Villegas, MD, MSC

Evaluation of Six Phenotypic Methods for the Detection of Carbapenemases in Gram-Negative Bacteria With Characterized Resistance Mechanisms

The Antibiotic Resistance Laboratory Network

Klebsiella pneumoniae 21 PCR

Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia

Use of Faropenem as an Indicator of Carbapenemase Activity

Expert rules. for Gram-negatives

Clinical significance of extended-spectrum

Abstract. Introduction. Methods. Editor: R. Canton

Robert A. Weinstein, MD Stroger (Cook County) Hospital Rush Medical College April 6, Disclosure: Grant funding from CDC & Sage Products, Inc.

Sepsis Treatment: Early Identification Remains the Key Issue

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis

Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test

Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011.

Emerging Infections, Outbreaks, and Steps of an Outbreak Investigation Across the Healthcare Continuum

breakpoints, cephalosporins, CLSI, Enterobacteriacae, EUCAST, review Clin Microbiol Infect 2008; 14 (Suppl. 1):

Cephalosporin MIC Distribution of Extended-Spectrum- -Lactamaseand pampc-producing Escherichia coli and Klebsiella Species

Transcription:

Epidemiology of the β-lactamase resistome among Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in the Chicago region Michael Y. Lin MD MPH 1, Karen Lolans BS 1, Rosie D. Lyles, MD, MHA 2, Trevor Wagner PhD 3, G. Terry Walker PhD 3, Robert A. Weinstein MD 1,2, Mary K. Hayden MD 1 for the CDC Prevention Epicenters Program (RAW PI) 1) Rush University Medical Center, Chicago, IL, 2) Cook County Health and Hospitals System, Chicago, IL, 3) OpGen, Inc., Gaithersburg, MD Funding sources: CDC Cooperative Agreement U54CK000161. No conflicts of interest.

Background Enterobacteriaceae that produce Klebsiella pneumoniae carbapenemase (KPC) often carry multiple β-lactamase genes, some conferring broad spectrum β-lactam resistance When 2 or more KPC-producing Enterobacteriaceae are recovered from the same ward or facility, a practical infection control question is whether the strains are related, suggesting an outbreak Distinct β-lactamase gene collections, or resistomes, may serve as markers of strain relatedness 2

Objectives 1) Characterize the β-lactamase resistomes of KPCproducing Enterobacteriaceae from the Chicago region 2) Assess whether resistome typing can identify significant clusters 3

Methods Design: Retrospective cohort analysis of 363 KPC-producing Enterobacteriaceae recovered from 177 distinct hospital point prevalence surveys from 2010-2014 in Chicago region For each isolate, we had epidemiologic information about hospital identity and date of surveillance Chicago Blue = 25 Hospitals (ICU); red = 7 LTACHs 4

Methods (cont.) β-lactamase resistome characterization: multiplex PCR targeting 49 gene families (Acuitas Resistome Test, OpGen) Carbapenemases Extended spectrum β-lactamase (ESBL) Plasmid-mediated AmpC-type β-lactamases Narrow spectrum β-lactamases 5

Methods (cont.) Distinct combinations of β-lactamase genes = resistome types For minority resistome types, we assessed temporal-spatial clusters (2 or more KPC-producing Enterobacteriaceae of identical species and resistome type recovered from the same facility/survey date) We tested cluster significance using exact statistical tests 6

Results 363 KPC-producing Enterobacteriaceae were recovered from 44% (77/177) of distinct hospital point prevalence surveys: - 86% K. pneumoniae, 7% E. coli, 6% Enterobacter spp. 24% (43/177) hospital surveys had 2 or more patients carrying KPC-producing Enterobacteriaceae 7

β-lactamase resistome Including bla KPC, isolates carried a median of five β-lactamase genes (range, 1 to 8) β-lactamase types n % SHV-type ESBL 167 46 TEM-type ESBL 17 5 CTX-M-type ESBL 12 3 Plasmid mediated AmpC-type 48 13 8

Using 23 resistance genes detected, we identified 38 unique resistome types (top 10 shown) Type Carbapenemase ESBL pampc Narrow spectrum β-lactamase Resistome type 1 2 3 4 5 6 7 8 9 10 Gene family KPC SHV G238S E240K TEM R164S TEM E104K CTX-M (CTX-M-1 subgroup) CMY-2/CFE-1 VEB SHV G238 E240 (WT) TEM G238 E240 (WT) TEM R164 (WT) TEM E104 (WT) Count (% of total [N=363]) 139 (38) 120 (33) 17 (5) 9 (2) 7 (2) 7 (2) 5 (1) 5 (1) 5 (1) 4 (1) Two most frequent resistome types accounted for 71% of all isolates 20 types were represented by at least 2 or more isolates 9

Cluster analysis Resistome types affecting 9 or less patients (from type 20 [n=2] to type 4 [n=9]) were analyzed for evidence of clustering 10

Example: Resistome 20 (n=2) Obs Organism Facility Date (coded) 17 E. cloacae P 19891 79 E. cloacae B 19569 No cluster identified 11

Example: Resistome 19 (n=2) Obs Organism Facility Date (coded) 156 K. pneumoniae LC 18700 293 K. pneumoniae LC 18700 1 cluster identified, P = 0.02 12

Example: Resistome 6 (n=7) Obs Organism Facility Date (coded) 122 K. pneumoniae LC 18700 125 K. pneumoniae LC 18700 154 K. pneumoniae LC 18700 200 K. pneumoniae LC 18700 229 K. pneumoniae LC 18700 232 K. pneumoniae LD 19821 264 K. pneumoniae LD 19821 1 2 2 clusters identified. Cluster 1, P <0.001; Cluster 2, P = 0.006 13

Cluster analysis results We found 17 temporal-spatial clusters (same resistome type, species, hospital, date of survey), involving 39/69 (57%) analyzed isolates Of 17 clusters, 15/17 (88%) were statistically significant (P < 0.05) 14

Limitations and Strengths Limitations Did not include analysis of non-β-lactamase resistome; inclusion of a broader resistome could improve strain differentiation Did not assess for outbreaks spanning more than 1 facility More discriminatory genetic testing (e.g., whole genome sequencing) is needed to confirm clustering as suggested by resistome and epidemiologic data Strength Isolates were obtained by point prevalence surveys, allowing recovery of KPC-producing Enterobacteriaceae from asymptomatic and symptomatic patients at a given time and location 15

Conclusions KPC-producing Enterobacteriaceae carry multiple β- lactamases, including ESBLs (SHV, TEM, CTX-M) and plasmidmediated AmpC In the Chicago region, about 70% of isolates were associated with 2 dominant resistome types that would require whole genome sequencing to resolve transmission linkages Facility clustering of minority resistome types suggests that a resistome-based surveillance system can identify some potential outbreaks 16

Thank you 17